Hematopoietic stem cell transplantation in adults with acute myeloid leukemia

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Mehdi HamadaniEdward A Copelan

Abstract

Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML.

References

Sep 13, 1979·The New England Journal of Medicine·E D ThomasP L Weiden
Nov 26, 1998·The New England Journal of Medicine·P RubinsteinC E Stevens
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·D BonnetS R Riddell
Mar 16, 2002·Bone Marrow Transplantation·C A LinkerJ L Wolf
Jul 26, 2002·British Journal of Haematology·Alan K BurnettUNKNOWN Medical Research Council Adult and Paediatric Working Parties
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hartmut BertzJürgen Finke
Dec 17, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H C FungS J Forman
Jan 8, 2004·Journal of the National Cancer Institute·Paul C NathanJoseph Beyene
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Nov 27, 2004·The New England Journal of Medicine·Vanderson RochaUNKNOWN Eurocord-Netcord Registry
Jan 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Feb 1, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Raymond WongSergio Giralt
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Koen van BesienW Stock
Sep 27, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vikas GuptaThomas Kiss
Dec 14, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ute HegenbartRainer Storb
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·William BlumEdward A Copelan

❮ Previous
Next ❯

Citations

Apr 12, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shinichiro MorishitaKazuhisa Domen
Sep 23, 2008·Pathology Oncology Research : POR·Kambiz BagheriSeyyed Mohammad Moazzeni
Jan 27, 2009·Bone Marrow Transplantation·A GratwohlUNKNOWN European Group for Blood and Marrow Transplantation
May 20, 2009·Future Oncology·Cortney V Jones, Edward A Copelan
Apr 27, 2011·Cancer Immunology, Immunotherapy : CII·Evelien L J SmitsBarbara-Ann Guinn
Jul 12, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jacquelyn Choate, Edward L Snyder
Jun 28, 2013·Journal of Cellular and Molecular Medicine·Liren QianJianliang Shen
Apr 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Khoan VuRizwan Romee
Feb 23, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Felicetto FerraraSalvatore Palmieri
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andre S JungEdward D Ball
Oct 30, 2016·Seminars in Hematology·Syed Y AltafEduardo Olavarria
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan FaderlHagop M Kantarjian
Oct 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Mehdi HamadaniMohamed A Kharfan-Dabaja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.